By Azra Raza, MD
Everyone agrees that early cancer detection saves lives. Yet, practically everyone is busy studying end-stage cancer.
Reviewing the history of carcinogenesis from 1911 on, I become unspeakably, depressed. Demoralized. For fifty years, massive intellectual and financial resources have been invested pursuing one dream. In the 1970s, a model evolved suggesting that one or a handful of mutations cause cancer that can be cured by one or a handful of magic bullets. Following a couple of early successes, the paradigm was tacitly accepted and has prevailed ever since. Sadly, it has not delivered as well for other cancers. Benefit to patients is nowhere near the enormity of the capital sunk.
Other articles in the series:
Part 1: The First Cell, Part 1: Old Yet A New Cancer Model
Part 2: The First Cell, Part 2: Transposed Heads
Part 4: The First Cell, Part 4: Giant Cells: “I Am Large, I Contain Multitudes”
part 5: The First Cell, Part 5: The Secret Sharer: Hybrid Cancer Cells